Sagimet Biosciences Biotech
Funding, team structure (meet the founders), partners and clients
Market - Biotech
Location - San Mateo, USA
Description - Sagimet is pharmaceutical company developing novel therapeutics to treat important diseases .Our lead product candidate TVB-2640 is an oral, highly potent, selective and reversible, first-in-class FASN inhibitor.
Team
Founder George Kemble
Funding
Sagimet Biosciences raised $80,000,000 with Kleiner Perkins and New Enterprise Associates and NEA, Rock Springs Capital, Altium Capital, Invus - 2/12/2021